[1] Yin, J., G. Li, X. Ren, G. Herrler. Select what you need: A comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. Journal of Biotechnology 127: 335–347 (2007).
[2] Qing, G., L. C. Ma, A. Khorchid, G. V. T. Swapna, T.K. Mal, M. M.
Takayama, B. Xia, S. Phadtare, H. Ke, T. Acton, G. T. Montelione, M. Ikura, M. Inouye. Cold-shock induced high-yield protein production in Escherichia coli.
Nature Biotechnology 22: 877–882 (2004).
[3] Schein, C.H., M. H. M. Noteborn. Formation of soluble recombinant proteins in Escherichia coli is favored by lower growth temperature. Biotechnology 6:
291–294 (1988).
[4] Esposito, D., D. K. Chatterjee. Enhancement of soluble protein expression through the use of fusion tags. Current Opinion in Biotechnology 17: 353–358 (2006).
[5] Linskens, M. H., P. D. Grootenhuis, M. Blaauw, B. Huisman-de Winkel, A.
Van Ravestein, P. J. Van Haastert, J. C. Heikoop. Random mutagenesis and screening of complex glycoproteins: expression of human gonadotropins in Dictyostelium discoideum. FASEB. Journal 13: 639–645 (1999).
[6] Hitzeman, R. A., F. E. Hagie, H. L. Levine, D. V. Goeddel, G. Ammerer, B. D.
Hall. Expression of a human gene for interferon in yeast. Nature 293: 717–722 (1981).
[7] Antoniukas, L., H. Grammel, U. Reichl. Production of hantavirus Puumala nucleocapsid protein in Saccharomyces cerevisiae for vaccine and diagnostics.
Journal of Biotechnology 124: 347–362 (2006).
[8] DiMiceli, L., V. Pool, J. M. Kelso, S. V. Shadomy, J. Iskander, V.A.E.R.S.
Team. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS). Vaccine 24: 703–707 (2006).
[9] Cregg, J. M., J. L. Cereghino, J. Shi, D. R. Higgins. Recombinant protein expression in Pichia pastoris. Molecular Biotechnology 16: 23–52 (2000).
[10] Cees, A. M., J. J. Hondel, P. J. Punt, R. F. M. Gorcom. Production of extracellular proteins by the filamentous fungus Aspergillus. Antonie Leeuwenhoek 61: 153–160 (1992).
[11] Sims, A. H., M. E. Gent, K. Lanthaler, N. S. Dunn-Coleman, S. G. Oliver, G.
D. Robson. Transcriptome analysis of recombinant protein secretion by Aspergillus nidulans and the unfolded-protein response in vivo. Applied And
Environmental Microbiology 71: 2737–2747 (2005).
[12] Jayapal, K. P., K. F. Wlaschin, M. G. S. Yap, W. Hu. Recombinant protein therapeutics from CHO cells - 20 years and counting. Chemical Engineering Progress 103: 40–47 (2007).
[13] Barta, A., K. Sommengruber, D. Thompson, K. Hartmuth, M. A. Matzke, A.
J. M. Matzke. The expression of a napoline synthase human growth hormone chimeric gene in transformed tobacco and sun flower callus tissue. Plant Molecular Biology 6: 347–357 (1986).
[14] Hiatt, A., R. Cafferkey, K. Bowdish. Production of antibodies in transgenic plants. Nature 342: 76–78 (1989).
[15] Hood, E. E., D. R. Witcher, S. Maddock, T. Meyer, C. Baszczynski, M. Bailey, P. Flynn, J. Register, L. Marshall, D. Bond, E. Kulisek, A. Kusnadi, R.
Evangelista, Z. Nikolov, C. Wooge, R. J. Mehigh, R. Hernan, W. K. Kappel, D.
Ritland, L. C. Ping, J. A. Howard. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Molecular Breeding 3: 291–306 (1997).
[16] Kusnadi, A., Z. L. Nikolov, J. A. Howard. Production of recombinant proteins in transgenic plants: practical considerations. Biotechnology and Bioengineering 56:
473–484 (1997).
[17] Giddings, G., G. Allison, D. Brooks, A. Carter. Transgenic plants as factories for biopharmaceuticals. Nature Biotechnology 18: 1151–1155 (2000).
[18] Kapusta, J., A. Modelska, M. Figlerowicz, T. Pniewski, M. Letellier, O.
Lisowa, V. Yusibov, H. Koprowski, A. Plucienniczak, A. B. Legocki. A plant-derived edible vaccine against hepatitis B virus. FASEB. Journal 13:
1796–1799 (1999).
[19] Tacket, C. O, H. S. Mason, G. Losonsky, J. D. Clements, M. M. Levine, C. J.
Arntzen. Immunogenicity in humans of a recombinant bacterial-antigen delivered in transgenic potato. Nature Medicine 4: 607–609 (1998).
[20] Tacket, C. O, H. S. Mason, G. Losonsky, M. K. Estes, M. M. Levine, C. J.
Arntzen. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. The Journal of Infectious Diseases 182: 302–305 (2000).
[21] Harl, N. E., R. G. Ginder, C. R. Hurburgh, S. Moline. The StarLink Situation.
Food and Chemical News (2000).
[22] United States Department of Agriculture (USDA). Release No. 0306.06 (2006).
[23] Guillamón, E., A. García-Lafuente, M. Lozano, M. D'Arrigo, M. A. Rostagno, A. Villares, , J. A. Martínez. Edible mushrooms: Role in the prevention of
cardiovascular diseases. Fitoterapia 81: 715–723 (2010).
[24] Kiho, T., J. Hui, A. Yamane, S. Ukai. Polysaccharides in fungi. XXXII.
Hypoglycemic activity and chemical properties of a polysaccharide from the cultural mycelium of Cordyceps sinensis. Biological & Pharmaceutical Bulletin 16: 1291–1293 (1993).
[25] Nakai, R., H. Masui, H. Horio, M. Ohtsuru. Effect of maitake (Grifola frondosa) water extract on inhibition of adipocyte conversion of C3H10T1/2B2C1 cells.
Journal of Nutritional Science and Vitaminology 45: 385–389 (1999).
[26] Ooi, V. E., F. Liu. Immunomodulation and anti-cancer activity of
polysaccharide-protein complexes. Current Medicinal Chemistry 7: 715–729 (2000).
[27] Wasser, S. P., A. L. Weis. Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Critical Reviews in
Immunology 19: 65–96 (1999).
[28] Binninger, D. M., C. Skrzynia, P. J. Pukkila, L. A. Casselton. DNA-mediated transformation of the basidiomycete Coprinus cinereus. EMBO Journal 6:
835–840 (1987).
[29] Munoz-Rivas, A., C. A. Specht, B. J. Drummond, E. Froeliger, C. P. Novotny, R. C. Ullrich. Transformation of the basidiomycete, Schizophyllum commune.
Molecular and General Genetics 205: 103–106 (1986).
[30] van de Rhee, M. D., P. M. Graca, H. J. Huizing, H. Mooibroek.
Transformation of the cultivated mushroom, Agaricus bisporus, to hygromycin B resistance. Molecular General Genetics 250: 252–258 (1996).
[31] Yanai, K., K. Yonekura, H. Usami, M. Hirayama, S. Kajiwara, T. Yamazaki, K. Shishido, T. Adachi. The integrative transformation of Pleurotus ostreatus using bialaphos resistance as a dominant selectable marker. Bioscience
Biotechnology and Biochemistry 60: 472–475 (1996).
[32] 范嫺蘄，以甘油醛-3-磷酸脫氫酶基因啟動子研究美白菇轉形系統，國立臺灣 大學微生物與生化學研究所碩士論文，2007。
[33] Pegler, D. N. Useful fungi of the world: the shii-take, shimeji, enoki-take, and nameko mushroom. Mycologist 17: 3–5 (2003).
[34] Combs, G. F. Jr., W. P. Gray. Chemopreventive agents: selenium. Pharmacology
& Therapeutics 79: 179–192 (1998).
[35] Ikekawa, T., H. Saitoh, W. Feng, H. Zhang, L. Li, T. Matsuzawa. Antitumor activity of Hypsizigus marmoreus. I. Antitumor activity of extracts and
polysaccharides. Chemical & Pharmaceutical Bulletin 40: 1954–1957 (1992).
[36] Ikekawa, T. Bunashimeji. Hypsizigus marmoreus: antitumor activity of extracts and polysaccharides. Food Reviews International, 11: 207–209 (1995).
[37] Lam, S. K., T. B. Ng. Hypsin, a novel thermostable ribosome-inactivating protein
with antifungal and antiproliferative activities from fruiting bodies of the edible mushroom Hypsizigus marmoreus. Biochemical and Biophysical Research Communications 285: 1071–1075 (2001).
[38] Tsuchida, K., Y. Aoyagi, S. Odani, T. Mita, M. Isemura. Isolation of a novel collagen-binding protein from the mushroom, Hypsizigus marmoreus, which inhibits the Lewis lung carcinoma cell adhesion to type IV collagen. Journal of Biological Chemistry 270: 1481–1484 (1995).
[39] Wong, J. H., H. X. Wang, T. B. Ng. Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus. Applied Microbiology and
Biotechnology 81: 669–674 (2008).
[40] Akihisa, T., S. G. Franzblau, H. Tokuda, M. Tagata, M. Ukiya, T. Matsuzawa, K. Metori, Y. Kimura, T. Suzuki, K. Yasukawa. Antitubercular activity and inhibitory effect on Epstein-Barr virus activation of sterols and
polyisoprenepolyols from an edible mushroom, Hypsizigus marmoreus. Biological
& Pharmaceutical Bulletin 28: 1117–1119 (2005).
[41] Chang, J. S., J. K. Son, G. Li, E. J. Oh, J. Y. Kim, S. H. Park, J. T. Bae, H. J.
Kim, I. S. Lee, O. M. Kim, N. Kozukue, J. S. Han, M. Hirose, K. R. Lee.
Inhibition of cell cycle progression on HepG2 cells by hypsiziprenol A9, isolated from Hypsizigus marmoreus. Cancer Letters 212: 7–14 (2004).
[42] De Groo, M. J., P. Bundtock, P. J. Hooykaas, A. G. Beijersbergen.
Agrobacterium tumefaciens-mediated transformation of filamentous fungi. Nature Biotechnology 16:839–842 (1998).
[43] Doring, F., M. Klapper, S. Theis, H. Daniel. Use of the
glyceraldehyde-3-phosphate dehydrogenase promoter for production of functional mammalian membrane transport proteins in the yeast Pichia pastoris.
Biochemical and Biophysical Research Communications 250: 531–535 (1998).
[44] Punt, P. J., R. P. Oliver, M. A. Dingemanse, P. H. Pouwels, C. A. van den Hondel. Transformation of Aspergillus based on the hygromycin B resistance marker from Escherichia coli. Gene 56: 117–124 (1987).
[45] Piechaczyk, M., J. M. Blanchard, L. Marty, C. Dani, F. Panabieres, S. El Sabouty, P. Fort, P. Jeanteur. Post-transcriptional regulation of
glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues.
Nucleic Acids Research 12: 6951–6963 (1984).
[46] Godio, R., R. Fouces, E. Guniña, J. Martin. Agrobacterium
tumefaciens-mediated transformation of an antitumor clavaric acid-producing basidiomycete Hypholoma sublateritium. Current Genetics 46: 287–294 (2004).
[47] Hanif, M., A.G. Pardo, M. Gorfer, M. Raudaskoski. T-DNA transfer and integration in the ectomycorrhizal fungus Suillus bovinus using hygromycin B as a selectable marker. Current Genetics 41: 183–188 (2002).
[48] 郭俊毅，食用菇異源基因表現系統之建立及其應用. 國立臺灣大學微生物與 生化學硏究所博士論文，2008。
[49] Zimmer, M. Green fluorescent protein (GFP): applications, structure, and related photophysical behavior. Chemical Reviews 102: 759–781 (2002).
[50] Zhang, G., V. Gurtu, S. R. Kain. An enhanced green fluorescent protein allows sensitive detection of gene transfer in mammalian cells. Biochemical and
Biophysical Research Communications 227: 707–711 (1996).
[51] Borovinskaya, M. A.,S. Shoji, K. Fredrick, J. H. D. Cate. Structural basis for hygromycin B inhibition of protein biosynthesis. RNA 14: 1590–1599 (2008).
[52] Gonzalez, A., A. Jimenez, D. Vazquez, J. E. Davies, D. Schindler. Studies on the mode of action of hygromycin B, an inhibitor of translocation in eukaryotes.
Biochimica et Biophysica Acta 521: 459–469 (1978).
[53] Broomfield, P. L. E. J. A. Hargreaves. A single amino-acid change in the iron-sulphur protein subunit of succinate dehydrogenase confers resistance to carboxin in Ustilago maydis. Current Genetics 22: 117–121 (1992).
[54] Honda, Y., T. Matsuyama, T. Irie, T. Watanabe, M. Kuwahara. Carboxin resistance transformation of the homobasidiomycete fungus Pleurotus ostreatus.
Current Genetics 37: 209–212 (2000).
[55] Irie, T., T. Sato, K. Saito, Y. Honda, T. Watanabe, M. Kuwahara, H. Enei.
Construction of a homologous selectable marker gene for Lentinus edodes transformation. Bioscience, Biotechnology, and Biochemistry 67: 2006–2009 (2003).
[56] Ito, Y., H. Muraguchi, Y. Seshime, S. Oita, S. O. Yanagi. Flutolanil and carboxin resistance in Coprinus cinereus conferred by a mutation in the cytochrome b 560 subunit of succinate dehydrogenase complex (Complex II).
Molecular Genetics and Genomics 272: 328–335 (2004).
[57] 陳佳珮，利用農桿菌媒介轉形法研究美白菇表達系統，國立臺灣大學微生物 與生化學硏究所碩士論文，2009。
[58] Burns, C., K. E. Gregory, M. Kirby, M. K. Cheung, M. Riquelme, T. J. Elliott, M. P. Challen, A. Bailey, G. D. Foster. Efficient GFP expression in the
mushrooms Agaricus bisporus and Coprinus cinereus requires introns. Fungal Genetics and Biology 42: 191–199 (2005).
[59] Lugones, L. G., K. Scholtmeijer, R. Klootwijk, J. G. Wessels. Introns are necessary for mRNA accumulation in Schizophyllum commune. Molecular
Microbiology 32: 681–689 (1999).
[60] Ma, B., M. B. Mayfield, M. H. Gold. The green fluorescent protein gene functions as a reporter of gene expression in Phanerochaete chrysosporium.
Applied and Environmental Microbiology 67: 948–955 (2001).
[61] Arakawa, T., D. K. Chong, J. L. Merritt, W. H. Langridge. Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Research 6: 403–413 (1997).
[62] Irie, T., Y. Honda, T. Hirano, T. Sato, H. Enei, T. Watanabe, M. Kuwahara.
Stable transformation of Pleurotus ostreatus to hygromycin B resistance using Lentinus edodes GPD expression signals. Applied Microbiology and
Biotechnology 56: 707–709 (2001).
[63] Bundock, P., P. J. J. Hooykaas. Integration of Agrobacterium tumefaciens T-DNA in the Saccharomyces cerevisiae genome by illegitimate recombination.
Proceedings of the National Academy of Sciences 93: 15272–15275 (1996).
[64] de Groot, M. J. A., P. Bundock, P. J. J. Hooykaas, A. G.M. Beijersbergen.
Agrobacterium tumefaciens-mediated transformation of filamentous fungi. Nature Biotechnology 16: 839–842 (1998).
[65] Kunik, T., T. Tzfira, Y. Kapulnik, Y. Gafni, C. Dingwall, V. Citovsky. Genetic transformation of HeLa cells by Agrobacterium. Proceedings of the National Academy of Sciences 98: 1871–1876 (2001).
[66] 徐韻涵，以農桿菌媒介轉形法進行金針菇表達系統之研究，國立臺灣大學微 生物與生化學硏究所碩士論文，2008。
[67] Wang, J., L. Guo, K. Zhang, Q. Wu, J. Lin. Highly efficient
Agrobacterium-mediated transformation of Volvariella volvacea. Bioresource Technology 99(17): 8524–8527 (2008).
[68] Gelvin, S. Agrobacterium-mediated plant transformation: the biology behind the
"gene-jockeying” tool. Microbiology and Molecular Biology Reviews 67: 16–37 (2003).
[69] McCullen, C., A. Binns. Agrobacterium tumefaciens and plant cell interactions and activities required for interkingdom macromolecular transfer. Annual Review of Cell and Developmental Biology 22: 101–127 (2006).
[70] Tzfira, T., V. Citovsky. Agrobacterium-mediated genetic transformation of plants:
biology and biotechnology. Current Opinion in Biotechnology 17: 147–154 (2006).
[71] Christie, P.J., K. Atmakuri, V. Krishnamoorthy, S. Jakubowski, E. Cascales.
Biogenesis, architecture, and function of bacterial type IV secretion systems.
Annual Review of Microbiology 59: 451–485 (2005).
[72] Gelvin, S. B. Finding a way to the nucleus. Current Opinion in Microbiology, 13:
53–58 (2010).
[73] Tzfira, T., J. Li, B. Lacroix, V. Citovsky. Agrobacterium T-DNA integration:
molecules and models. TRENDS in Genetics 20(8): 375-383. (2004).
[74] Zhu, T., M. Guo, Z. Tang, M. Zhang, Y. Zhuang, J. Chu, S. Zhang. Efficient generation of multi-copy strains for optimizing secretory expression of porcine insulin precursor in yeast Pichia pastoris. Journal of Applied Microbiology 107:
954–963 (2009).
[75] Gelvin S. B., S. I. Kim. Effect of chromatin upon Agrobacterium T-DNA integration and transgene expression. Biochimica et Biophysica Acta 1769:
410–421 (2007).
[76] Kemppainen, M. J. Pardo A. G. pHg/pSILBAγ vector system for efficient gene silencing in homobasidiomycetes: optimization of ihpRNA – triggering in the mycorrhizal fungus Laccaria bicolor. Microbial Biotechnology 3: 178–200 (2010).
[77] Wälti, M.A., C. Villalba, R.M. Buser, A. Grünler, M. Aebi, M. Künzler.
Targeted gene silencing in the model mushroom Coprinus cinerea (Coprinus cinereus) by expression of homologous hairpin RNAs. Eukaryot Cell 5: 732–744 (2006).
[78] Nevalainen, K. M., V. S. Te'o, P. L. Bergquist. Heterologous protein expression in filamentous fungi. Trends in Biotechnology 23: 468–474 (2005).
[79] Obembe, O. O., J. O. Popoola, S. Leelavathi, S. V. Reddy. Advances in plant molecular farming. Biotechnology Advances 29: 210–222 (2011).
[80] Michielse, C. B., P. J. Hooykaas, C. A. van den Hondel, A. F. Ram.
Agrobacterium-mediated transformation as a tool for functional genomics in fungi.
Current Genetics 48: 1–17 (2005).